Exactly BK,.... but the company has got to make it to, and then through that point first,...
But that's going to be a fun set of numbers to watch for 'just' Flucide.
And the market breakthrough will grease the skids for everything that following it up in the pipeline. Be that Denguecide, an Ebolacide formulation, Oral Flucide, Herpescide, or maybe even an HIV treatment.
Gotta do the work first,... but each step through the process will lower perceived risk for NNVCs future, and should be accompanied by a nice, stepwise move upwards as the hurdles are crossed.